Munich — The foun­der and CEO of SCHWIND eye-tech-solu­­ti­ons GmbH, Mr. Rolf Schwind, was advi­sed by the Munich and Frank­furt offices of the inter­na­tio­nal law firm Weil, Gotshal & Manges LLP in connec­tion with the sale of the majo­rity stake in SCHWIND-eye-tech-solu­­ti­ons GmbH previously held by the finan­cial inves­tor Ardian. Ardian sells its stake to the private equity invest­ment company Adagia Part­ners, which thus beco­mes the new majo­rity shareholder.

The manage­ment team around Mr. Rolf Schwind (CEO), Mr. Dome­nic von Planta (COO) and Mr. Dirk Rosen­lö­cher (CFO) will conti­nue to lead the busi­ness of the SCHWIND Group. Weil had alre­ady advi­sed Mr. Rolf Schwind on the entry of Ardian in 2016.

SCHWIND eye-tech-solu­­ti­ons GmbH, loca­ted in Klein­ost­heim, Germany, is one of the leading specia­lists for refrac­tive and thera­peu­tic corneal surgery and eye laser systems. The Group deve­lops, manu­fac­tures and markets a compre­hen­sive port­fo­lio of products for the treat­ment of ametro­pia and corneal diseases.

The Weil tran­sac­tion team was led by Munich Corpo­rate Part­ner Dr. Barbara Jagers­ber­ger (photo ) and supported by Coun­sel Benja­min Rapp (Tax, Frank­furt) and Asso­cia­tes Madleen Düdder, Maxi­mi­lian Schmitt, Stef­fen Giolda (all Corpo­rate, Munich), Lukas Reisch­mann (Tax, Frank­furt) and Mareike Pfeif­fer (Labor Law, Frankfurt).

About WEIL
Weil, Gotshal & Manges is an inter­na­tio­nal law firm with more than 1,100 lawy­ers, inclu­ding appro­xi­m­ately 300 part­ners. Weil is head­quar­te­red in New York and has offices in Boston, Dallas, Frank­furt, Hong Kong, Hous­ton, London, Miami, Munich, Paris, Beijing, Prince­ton, Shang­hai, Sili­con Valley, Warsaw and Washing­ton, D.C.